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http://dxObjectives: Open thoracoabdominal aortic aneurysm (TAAA) repair traditionally carries substantial
perioperative morbidity and mortality, primarily from distal aortic ischemia. Advances in surgical techniques,
adjuncts, and strategies have greatly improved outcomes.
Methods: We analyzed outcomes of 1267 open consecutive TAAA repairs between January 2005 and
September 2013. We provided cold crystalloid renal perfusion whenever the renal ostia were accessible; accord-
ing to extent of repair, we selectively used left heart bypass and provided isothermic blood to the celiac axis and
superior mesenteric artery. Repair was extensive (Crawford extent I and II) in 717 cases (57%). Left heart bypass
was used in 645 (51%) cases, cold crystalloid renal perfusion in 987 (78%), and isothermic visceral perfusion in
318 (25%). Additional patient-specific surgical adjuncts included endarterectomy of renal or visceral vessels,
open stent placement within these vessels, or use of both techniques; at least one was used in 447 repairs (35%).
Results: Thirty-day survival was 95% (1198/1267); overall operative mortality was 8% (104/1267). Acute
renal dysfunction occurred in 155 (12%), renal failure requiring hemodialysis at hospital discharge in 84
(7%), and bowel ischemia in 9 (<1%). Extent II and III TAAA repairs carried the highest risks of postoperative
renal dysfunction and renal failure requiring hemodialysis at hospital discharge.
Conclusions: Contemporary protective strategies allow open TAAA repair with substantially fewer renal and
visceral ischemic complications. Although bowel ischemia is uncommon, renal failure remains a concern,
especially in extent II and extent III TAAA repairs. Additional studies are needed to identify and improve renal
protection strategies. (J Thorac Cardiovasc Surg 2014;148:2963-6)A
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DOpen repair of thoracoabdominal aortic aneurysm (TAAA)
traditionally carries a formidable risk of perioperative
morbidity and mortality, primarily as a result of distal aortic
ischemia during repair. Although renal dysfunction after
TAAA repair occurs in as many as 28% of patients, it neces-
sitates postoperative dialysis in 4% to 11% of cases.1-5
Preoperative renal impairment and postoperative renal
complications are commonly associated with worsened
long-term survival6 and increased postoperative mortality.4-9
Although cases of nonrenal visceral and bowel ischemia
after TAAA repair are fortunately uncommon, they have
been associated with substantial mortality and morbidity.9,10
Recent advances in surgical techniques and adjuncts have
significantly improved surgical outcomes after open TAAA
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The Journal of Thoracic and Carapproaches to renal and visceral protection and report our
contemporary experience with open TAAA repair.
For decades, surgeons have developed several perfusion
strategies to minimize the ischemic damage to the down-
stream organs while the aorta is clamped. One strategy is
the use of a passive shunt to provide distal aortic perfusion.
Its potential advantage lies in providing pulsatile arterial
flow to distal organs. This technique is infrequently used
because of the popularity of mechanical circulatory support
and an inherent inability to conveniently adjust flow rates or
distal aortic pressure. Passive shunting to deliver inline
mesenteric perfusion combined with cold crystalloid renal
perfusion to maintain a core renal temperature at 25C
has produced satisfactory results.5
With the advancement of extracorporeal circulation
technology, two primary approaches have emerged to
maintain distal aortic perfusion and provide selective
visceral perfusion. The first uses a left heart bypass
(LHB) circuit.1,3,7-9 LHB can be used to maintain distal
perfusion and pressure and be adjusted as needed to
sustain stable hemodynamics. We use LHB as a closed
circuit with the addition of a reservoir to salvage shed
blood. LHB use is associated with an increased incidence
of postoperative renal failure14 and isothermic visceral
and renal perfusion15 was a concern in some initial studies.
Jacobs and associates16 postulated that this may be due to
inadequate renal perfusion pressure. They proposed using
catheters equipped with pressure channels to maintain the
perfusion pressure at 60 mm Hg or higher, particularlydiovascular Surgery c Volume 148, Number 6 2963
Abbreviations and Acronyms
LHB ¼ left heart bypass
TAAA ¼ thoracoabdominal aortic aneurysm
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Din patients with chronic hypertension or chronic renal
insufficiency (eg, 85 mm Hg).
Various strategies to provide selective visceral perfusion
from modified LHB circuits have been described8,12,17 in
TAAA repair. Hassoun and coworkers8 compared the
outcomes of either isothermic (37C) or cold blood (4C)
visceral perfusion of all 4 branching arteries. Of the 347
patients studied, 81 (23%) had development of acute renal
failure. Similar acute renal failure rates were found
among patients receiving the different perfusion strategies;
however, a significantly lower in-hospital mortality was
found when using cold blood (27% vs 56%; P<.02).
In addition, during TAAA repair, full cardiopulmonary
bypass may be used with a wide range of protective
hypothermia strategies, such as mild (34C) to profound
(18C) systemic hypothermia, during the repair. Partial
cardiopulmonary bypass, with 3 roller pumps for femoral-
femoral bypass, celiac axis and superior mesenteric artery
perfusion, and bilateral renal perfusion, may also be
used.18 Kulik and colleagues2 recently reported their expe-
rience with extent I, II, and III TAAA repairs performed
with cardiopulmonary bypass and deep hypothermic
(22C or lower) circulatory arrest, with a 7% incidence
(n ¼ 15) of new-onset acute renal failure necessitating
dialysis out of 218 patients. More than half of these
patients receiving dialysis died after multisystem organ
dysfunction, but only 4% of early survivors required
temporary dialysis.
Our current approach to renal and visceral protection for
repair of TAAA has evolved from the results of 2 of our
randomized clinical trials11,12 and has been described in
recent publications.19,20 In the first trial, we compared
postoperative renal dysfunction in patients receiving
either isothermic blood or cold crystalloid for renal
perfusion.11 After multivariate analysis, we found that
cold crystalloid perfusion independently protected against
renal dysfunction.11
Subsequently, we compared renal outcomes in patients
receiving either cold blood or cold crystalloid for renal
perfusion.12We found no significant difference between pa-
tients with regard to renal failure or early death; however,
we noted a statistically nonsignificant trend toward less
paraplegia in the cold crystalloid group.
Currently, we apply a multimodal approach to renal
and visceral protection. We use moderate heparinization
(1 mg/kg) and mild passive hypothermia (nasopharyngeal
temperature near 33C) in all repairs. Whenever there is
access to renal artery ostia, we use intermittent cold2964 The Journal of Thoracic and Cardiovascular Surcrystalloid perfusion. Generally, to provide renal perfusion
we prefer to use cold crystalloid, rather than cold blood, as it
is less cumbersome to use because an LHB circuit is not
needed. We add mannitol (12.5 g/L) and methylpredniso-
lone (125 mg/L) to the Ringer’s lactate solution, cool the
perfusate to 4C, and administer it with a separate roller
head pump connected to balloon-tip perfusion catheters.
An initial bolus of 200 to 300 mL of cold crystalloid
perfusate is administered per kidney, followed by
intermittent infusion of 100 to 150 mL per kidney
delivered every 10 to 15 minutes until arterial flow is
reestablished. The volume and frequency are adjusted to
avoid fluid overload and hypothermia (>32C temperature).
For extent I and II repairs, we routinely use LHB,
maintaining the flows at 1.5 to 2.5 L/min. After the
completion of proximal anastomosis, LHB is stopped, and
the remaining aortic aneurysm is opened. During
reconstruction, the celiac axis and superior mesenteric
artery are perfused through balloon perfusion catheters
with isothermic blood from the LHB circuit. A continuous
selective perfusion with isothermic blood is delivered at a to-
tal flow rate of 300 to 500 mL/min until the balloon catheters
are removed near completion of the visceral anastomosis.
Recent aortic guidelines recommend the use of cold
blood or cold crystalloid renal perfusion (class IIB, level
of evidence B)21; however, the technique and addition of
various additives cause this perfusion to vary among
centers. A recent study compared the renal perfusion
strategy of using cold crystalloid solution enriched with
histidine-tryptophan-ketoglutarate with cold Ringer’s
lactate solution in patients undergoing open TAAA repair.
After 1:1 propensity score matching of 42 patients in each
group, the observed freedom from acute kidney injury
was significantly greater in the histidine-tryptophan-
ketoglutarate group (38.1%) than in the Ringer’s lactate
solution group (9.5%; P ¼ .002), despite longer total renal
ischemic time in the former group.22 Currently a phase II,
randomized, placebo-controlled, double-blind study is in
progress to evaluate the role of a hypoxia-inducible factor
prolyl-hydroxylase inhibitor in reducing ischemic events
in patients undergoing thoracoabdominal and descending
thoracic aortic aneurysm repair.23
A significant proportion of patients with TAAA have
concomitant visceral and renal artery occlusive disease.24
To improve blood flow through occluded visceral arteries,
endarterectomy may be performed, or balloon-expandable
stents may be used.25 The experience of Svensson and
associates14,24 demonstrated that renal endarterectomy is
associated with significantly less renal failure in patients
with preexisting renal dysfunction. Additionally, although
all 4 of the branching visceral arteries are commonly
attached as an island patch, individual small-diameter grafts
may be used as necessary to bypass the visceral vessels; this
is particularly useful if the left renal artery becomes widelygery c December 2014
TABLE 1. Techniques of renal and visceral perfusion and outcomes in 1267 patients undergoing open thoracoabdominal aortic aneurysm repair
(January 2005-September 2013)
All patients
(n ¼ 1267)
Extent I
(n ¼ 319)
Extent II
(n ¼ 398)
Extent III
(n ¼ 261)
Extent IV
(n ¼ 289)
Protective technique (no.)
Left heart bypass 645 (51%) 262 (82%) 355 (89%) 26 (10%) 2 (1%)
Selective celiac or SMA perfusion 318 (25%) 37 (12%) 255 (64%) 20 (8%) 6 (2%)
Cold crystalloid renal perfusion 987 (78%) 121 (38%) 357 (90%) 232 (89%) 277 (96%)
Hypothermic circulatory arrest 28 (2%) 17 (5%) 10 (3%) 1 (<1%) 0
Perfusion and ischemic times (min, median and interquartile range)
Left-heart bypass time 25 (19-30) 27 (21-31) 23 (17-30) 20 (17-27) 19 (14-23)
Right kidney
Total ischemic time 45 (33-58) 45 (36-54) 60 (51-71) 37 (31-46) 33 (27-43)
Unprotected ischemic time 33 (26-43) 24 (17-31) 40 (33-48) 36 (30-44) 33 (26-43)
Left kidney
Total ischemic time 49 (37-64) 45 (36-55) 64 (54-79) 44 (35-56) 40 (30-51)
Unprotected ischemic time 37 (27-50) 25 (17-31) 44 (35-56) 42 (33-54) 40 (30-50)
Celiac axis
Total ischemic time 45 (34-58) 45 (36-54) 59 (50-70) 39 (32-47) 33 (26-43)
Unprotected ischemic time 34 (26-43) 24 (17-31) 39 (32-48) 37 (30-46) 33 (26-43)
Superior mesenteric artery
Total ischemic time 45 (34-58) 45 (37-54) 59 (50-70) 39 (32-47) 33 (26-43)
Unprotected ischemic time 33 (26-43) 24 (17-31) 39 (32-48) 37 (30-46) 33 (26-43)
Patient-specific adjuncts for renal and visceral vessels (no.)
Endarterectomy 396 (31%) 22 (7%) 110 (28%) 119 (46%) 145 (50%)
Placement of stent 159 (13%) 9 (3%) 47 (12%) 44 (17%) 59 (20%)
Endarterectomy or stent or both 447 (35%) 27 (8%) 126 (32%) 130 (50%) 164 (57%)
Outcomes (no.)
Acute renal dysfunction 155 (12%) 29 (9%) 66 (17%) 34 (13%) 26 (9%)
Renal failure requiring dialysis at hospital discharge 84 (7%) 10 (3%) 36 (9%) 23 (9%) 15 (5%)
Bowel ischemia 9 (1%) 0 2 (1%) 5 (2%) 2 (1%)
Total ischemic time is defined as the interval between application of the initial aortic crossclamp and restoration of normal blood flow to a region; unprotected ischemic time is
defined as the region’s total ischemic time minus the time that region was perfused during left heart bypass or selective visceral or renal perfusion. All the presented data vary
significantly depending on the extent of repair (P  .05). SMA, Superior mesenteric artery.
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visceral vessels are so far apart that island patch
reimplantation would not be appropriate.20
The use of visceral stents in treating renal and mesen-
teric occlusive disease in patients undergoing TAAA
repair is a relatively new strategy to enhance visceral
perfusion.25 Visceral stents are useful in obliterating the
false lumen in concomitant aortic dissection, securing
the intimal edges after endarterectomy, facilitating the
safe placement of balloon catheters, and helping to keep
the ostia patent near the patch anastomosis. Although
these adjuncts are usually safe and effective, some of the
drawbacks include difficultly in safely manipulating a
friable arterial wall after endarterectomy, time-
consuming individual branch anastomoses, possibility of
vessel perforation or stent migration after the stent deploy-
ment, and risk of thrombosis.
Of 1267 contemporary open TAAA repairs, 411 (32%)
involved separate small-diameter grafts for left renal artery
bypasses, 192 (15%) for right renal artery bypasses, and
125 (10%) for celiac artery or superior mesenteric artery
bypasses. Either endarterectomy or stents were used inThe Journal of Thoracic and Car447 (35%) repairs (Table 1). The operative mortality was
8%, similar to that in our previously published reports.
Although the overall incidence of acute renal dysfunction
was 12%, only 7% of repairs necessitated dialysis at the
time of discharge. The incidence of renal dysfunction was
highest after extent II TAAA repair, which correlates with
prolonged protected and unprotected renal ischemia times
(Table 1). Although bowel ischemia occurred in only 9
(1%) patients, it had a substantial attendant mortality of
88% (8 of 9 patients).
Contemporary protective strategies enable patients to
undergo open TAAA repair with substantially fewer renal
and visceral ischemic complications than in previous de-
cades. The risk of renal failure, however, especially in
extent II and extent III TAAA repairs, remains a concern
because of the poor long-term prognosis of these patients.
Additional studies are needed to identify and improve renal
protection strategies for patients undergoing open TAAA
repair.
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